Paul Bresge is the founder of Ray Therapeutics. Ray Therapeutics has raised $230M in total funding. Latest round: Series B. Based in Berkeley, California.
Paul Bresge is the co-founder and chief executive officer of Ray Therapeutics, a clinical-stage biotechnology company developing optogenetic vision-restoration therapies for degenerative retinal diseases. He co-founded the company in 2021, and Ray Therapeutics has since advanced RTX-015 into clinical development and raised multiple financing rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library